A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.

BACKGROUND: Associations of obesity and obesity-related metabolic factors (adiposity factors) with uterine corpus cancer (UCC) and ovarian cancer (OVC) risk have been described. Still, a cause-effect relationship and the underlying mediators remain unclear, particularly for low-incidence populations...

Full description

Bibliographic Details
Main Authors: Meei-Maan Wu, Hui-Chi Chen, Chi-Ling Chen, San-Lin You, Wen-Fang Cheng, Chi-An Chen, Te-Chang Lee, Chien-Jen Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4130554?pdf=render
_version_ 1818990070677372928
author Meei-Maan Wu
Hui-Chi Chen
Chi-Ling Chen
San-Lin You
Wen-Fang Cheng
Chi-An Chen
Te-Chang Lee
Chien-Jen Chen
author_facet Meei-Maan Wu
Hui-Chi Chen
Chi-Ling Chen
San-Lin You
Wen-Fang Cheng
Chi-An Chen
Te-Chang Lee
Chien-Jen Chen
author_sort Meei-Maan Wu
collection DOAJ
description BACKGROUND: Associations of obesity and obesity-related metabolic factors (adiposity factors) with uterine corpus cancer (UCC) and ovarian cancer (OVC) risk have been described. Still, a cause-effect relationship and the underlying mediators remain unclear, particularly for low-incidence populations. We aimed to prospectively determine whether adiposity factors could predict the development of UCC and OVC in Taiwanese women. To explore the biological mediators linking adiposity factors to cancer risk, we examined the association of two adipokines, leptin and adiponectin, with the gynecological cancers. METHODS: Totally, 11,258 women, aged 30-65, were recruited into the Community-Based Cancer Screening Program (CBCSP) study during 1991-1993, and were followed for UCC and OVC cases until December 31, 2011. Cox proportional hazard models were used to estimate hazard ratios (HRs). Adiposity factors and risk covariates were assessed at recruitment. Newly-developed cancer cases were determined from data in the government's National Cancer Registry and Death Certification System. For adipokienes study, a nested case-control study was conducted within the cohort. Baseline plasma samples of 40 incident gynecological cancer cases and 240 age-menopause-matched controls were assayed for adipokines levels. FINDINGS: There were 38 and 30 incident cases of UCC and OVC, respectively, diagnosed during a median 19.9 years of follow-up. Multivariate analysis showed that alcohol intake (HR = 16.00, 95%  = 4.83-53.00), high triglyceride levels (HR = 2.58, 95% = 1.28-5.17), and years of endogenous estrogen exposure per 5-year increment (HR = 1.91, 95%  = 1.08-3.38) were associated with increased UCC risk. High body mass index (BMI ≥ 27 kg/m(2), HR = 2.90, 95%  = 1.30-6.46) was associated with increased OVC risk. Analysis further showed an independent effect of adipokines on UCC and OVC risk after adjustment of the risk covariates. CONCLUSION: We provided evidence that alcohol intake, high triglyceride levels and long endogenous estrogen exposure increase UCC risk, whereas obesity positively predicts OVC risk. Circulating adipokines may mediate the link of adiposity factors to gynecological cancer risk.
first_indexed 2024-12-20T19:48:32Z
format Article
id doaj.art-5c8e6dec0ada46bbb6ef3be0ccad4eb3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T19:48:32Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5c8e6dec0ada46bbb6ef3be0ccad4eb32022-12-21T19:28:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0198e10463010.1371/journal.pone.0104630A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.Meei-Maan WuHui-Chi ChenChi-Ling ChenSan-Lin YouWen-Fang ChengChi-An ChenTe-Chang LeeChien-Jen ChenBACKGROUND: Associations of obesity and obesity-related metabolic factors (adiposity factors) with uterine corpus cancer (UCC) and ovarian cancer (OVC) risk have been described. Still, a cause-effect relationship and the underlying mediators remain unclear, particularly for low-incidence populations. We aimed to prospectively determine whether adiposity factors could predict the development of UCC and OVC in Taiwanese women. To explore the biological mediators linking adiposity factors to cancer risk, we examined the association of two adipokines, leptin and adiponectin, with the gynecological cancers. METHODS: Totally, 11,258 women, aged 30-65, were recruited into the Community-Based Cancer Screening Program (CBCSP) study during 1991-1993, and were followed for UCC and OVC cases until December 31, 2011. Cox proportional hazard models were used to estimate hazard ratios (HRs). Adiposity factors and risk covariates were assessed at recruitment. Newly-developed cancer cases were determined from data in the government's National Cancer Registry and Death Certification System. For adipokienes study, a nested case-control study was conducted within the cohort. Baseline plasma samples of 40 incident gynecological cancer cases and 240 age-menopause-matched controls were assayed for adipokines levels. FINDINGS: There were 38 and 30 incident cases of UCC and OVC, respectively, diagnosed during a median 19.9 years of follow-up. Multivariate analysis showed that alcohol intake (HR = 16.00, 95%  = 4.83-53.00), high triglyceride levels (HR = 2.58, 95% = 1.28-5.17), and years of endogenous estrogen exposure per 5-year increment (HR = 1.91, 95%  = 1.08-3.38) were associated with increased UCC risk. High body mass index (BMI ≥ 27 kg/m(2), HR = 2.90, 95%  = 1.30-6.46) was associated with increased OVC risk. Analysis further showed an independent effect of adipokines on UCC and OVC risk after adjustment of the risk covariates. CONCLUSION: We provided evidence that alcohol intake, high triglyceride levels and long endogenous estrogen exposure increase UCC risk, whereas obesity positively predicts OVC risk. Circulating adipokines may mediate the link of adiposity factors to gynecological cancer risk.http://europepmc.org/articles/PMC4130554?pdf=render
spellingShingle Meei-Maan Wu
Hui-Chi Chen
Chi-Ling Chen
San-Lin You
Wen-Fang Cheng
Chi-An Chen
Te-Chang Lee
Chien-Jen Chen
A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.
PLoS ONE
title A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.
title_full A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.
title_fullStr A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.
title_full_unstemmed A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.
title_short A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels.
title_sort prospective study of gynecological cancer risk in relation to adiposity factors cumulative incidence and association with plasma adipokine levels
url http://europepmc.org/articles/PMC4130554?pdf=render
work_keys_str_mv AT meeimaanwu aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT huichichen aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT chilingchen aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT sanlinyou aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT wenfangcheng aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT chianchen aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT techanglee aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT chienjenchen aprospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT meeimaanwu prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT huichichen prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT chilingchen prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT sanlinyou prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT wenfangcheng prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT chianchen prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT techanglee prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels
AT chienjenchen prospectivestudyofgynecologicalcancerriskinrelationtoadiposityfactorscumulativeincidenceandassociationwithplasmaadipokinelevels